BioWorld MedTech

Jan. 24, 2014

J.P. Morgan Healthcare Conference: Private ophthalmic companies make their pitches to receptive audience

SAN FRANCISCO — Although this annual conference has long been and continues to be dominated by publicly-owned healthcare companies, once again this year there was an impressive roster of attractive private companies. Read More

Medtronic gains approval for MRI to be used with pacing systems

Washington Roundup: FDA publishes draft to update 1998 animal materials guidance

Report from Asia: Trademark trouble follows J&J overseas to Chinese market

Deals roundup: Valeant tendered purchase of outstanding Solta shares

BioWorld Survey: Let Us Know What You Think!

Financings roundup: OrthoAccel Tech snags $5 million equity round

Agreements/contracts: KCI gets new designations from Novation for V.A.C.Ulta

Product briefs

People in Places

MDD's Diagnostics Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...